UCLA ECON M204L: Seminar: Pharmaceutical Economics and Policy

You are looking at Fall 2025. That term is over, so these are last term's numbers rather than seats you can take. dibs holds 1,964 sections for Fall 2025, read about 1 month ago. Separately, it has finished 527 of the 3,572 courses on its current checking list for this term. Future-term coverage is incomplete, so a course with nothing here may simply not have been reached yet. Back to Fall 2026

Sections & times

Also listed as HLT POL M204A: the same class, and each department holds its own seats and its own grade history.

Grades

No grade history for this course: the data runs Fall 2021 to Fall 2025. Sections for Fall 2025 are below.

Grade records describe outcomes. For what a course is like to take, read student reviews written on dibs below or follow the separate external review link.

Reviews for ECON M204L

Workload and assignments

Work types reported in BruinWalk reviews of this course, across recorded instructors and terms. They may differ from this term's syllabus.

dibs has not read this course’s reviews, so it cannot say what kind of work it sets. That is dibs not having looked. It is not a course without papers or exams, and the reviews linked below are the answer until dibs catches up.

Read the source reviews

What comes first

The chain dibs can see is 1 course long before ECON M204L. Read from Fall 2026, because dibs has not read a class page for ECON M204L in Fall 2025 and a department can change what it requires. This is a floor, not a deadline: dibs has not read a class page for HLT POL M236, so the real chain can only be longer than this, never shorter.

Counted in courses rather than quarters: dibs does not know which of them a department lets you take together.

From the registrar's catalog

(Same as Health Policy M204A.) Seminar, three hours every other week. Requisite: Health Policy M236. Limited to graduate public health and economics students. Various topics in economics of pharmaceutical industry, including rates of innovation, drug regulation, and economic impact of pharmaceuticals. In Progress grading (credit to be given only on completion of courses M204M and M204N).

Sections in Fall 2025

dibs has not read Fall 2025 for this course, so it cannot say whether it runs. dibs reads the term you are enrolling in first and the rest a little at a time; the registrar's own listing is the answer until this one catches up.

From the people who took it

Student reviews

What taking ECON M204L was like: the work, the teaching, and what students wish they’d known.

Write a review

Your experience could be the first.

No student reviews are available to read on dibs for this course yet. Took it? Tell the next person what helped, what was hard, and how you spent your time.

Looking for more perspectives?

External reviews are separate and do not count toward the dibs rating.

Read reviews on BruinWalk

Community guidelines